These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1018 related articles for article (PubMed ID: 10714729)

  • 1. Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial.
    Sees KL; Delucchi KL; Masson C; Rosen A; Clark HW; Robillard H; Banys P; Hall SM
    JAMA; 2000 Mar; 283(10):1303-10. PubMed ID: 10714729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost and cost-effectiveness of standard methadone maintenance treatment compared to enriched 180-day methadone detoxification.
    Masson CL; Barnett PG; Sees KL; Delucchi KL; Rosen A; Wong W; Hall SM
    Addiction; 2004 Jun; 99(6):718-26. PubMed ID: 15139870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled trial of prescribed heroin in the treatment of opioid addiction.
    March JC; Oviedo-Joekes E; Perea-Milla E; Carrasco F;
    J Subst Abuse Treat; 2006 Sep; 31(2):203-11. PubMed ID: 16919749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.
    Mattick RP; Breen C; Kimber J; Davoli M
    Cochrane Database Syst Rev; 2002; (4):CD002209. PubMed ID: 12519570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial of supervised injectable versus oral methadone maintenance: report of feasibility and 6-month outcome.
    Strang J; Marsden J; Cummins M; Farrell M; Finch E; Gossop M; Stewart D; Welch S
    Addiction; 2000 Nov; 95(11):1631-45. PubMed ID: 11219367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index.
    Strain EC; Stitzer ML; Liebson IA; Bigelow GE
    J Clin Psychopharmacol; 1996 Feb; 16(1):58-67. PubMed ID: 8834420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.
    Mattick RP; Breen C; Kimber J; Davoli M
    Cochrane Database Syst Rev; 2003; (2):CD002209. PubMed ID: 12804430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of abstinence or continued drug use among methadone maintenance patients and their relation to treatment retention.
    White WL; Campbell MD; Spencer RD; Hoffman HA; Crissman B; DuPont RL
    J Psychoactive Drugs; 2014; 46(2):114-22. PubMed ID: 25052787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.
    Mattick RP; Breen C; Kimber J; Davoli M
    Cochrane Database Syst Rev; 2009 Jul; 2009(3):CD002209. PubMed ID: 19588333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial.
    Strain EC; Bigelow GE; Liebson IA; Stitzer ML
    JAMA; 1999 Mar; 281(11):1000-5. PubMed ID: 10086434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender-specific predictors of retention and opioid abstinence during methadone maintenance treatment.
    Levine AR; Lundahl LH; Ledgerwood DM; Lisieski M; Rhodes GL; Greenwald MK
    J Subst Abuse Treat; 2015 Jul; 54():37-43. PubMed ID: 25795601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voucher-based reinforcement of opiate abstinence during methadone detoxification.
    Robles E; Stitzer ML; Strain EC; Bigelow GE; Silverman K
    Drug Alcohol Depend; 2002 Jan; 65(2):179-89. PubMed ID: 11772479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-efficacy and HIV risk behaviors among heroin users in Taiwan.
    Ko NY; Wang PW; Wu HC; Yen CN; Hsu ST; Yeh YC; Chung KS; Yen CF
    J Stud Alcohol Drugs; 2012 May; 73(3):469-76. PubMed ID: 22456252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methadone maintenance at different dosages for opioid dependence.
    Faggiano F; Vigna-Taglianti F; Versino E; Lemma P
    Cochrane Database Syst Rev; 2003; (3):CD002208. PubMed ID: 12917925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral drug and HIV risk reduction counseling (BDRC) in MMT programs in Wuhan, China: a pilot randomized clinical trial.
    Chawarski MC; Zhou W; Schottenfeld RS
    Drug Alcohol Depend; 2011 Jun; 115(3):237-9. PubMed ID: 21159452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial of 6-month methadone maintenance with standard or minimal counseling versus 21-day methadone detoxification.
    Gruber VA; Delucchi KL; Kielstein A; Batki SL
    Drug Alcohol Depend; 2008 Apr; 94(1-3):199-206. PubMed ID: 18243585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient satisfaction with methadone maintenance treatment: the relevance of participation in treatment and social functioning.
    Trujols J; Garijo I; Siñol N; del Pozo J; Portella MJ; Pérez de los Cobos J
    Drug Alcohol Depend; 2012 Jun; 123(1-3):41-7. PubMed ID: 22071121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A controlled trial of buprenorphine treatment for opioid dependence.
    Johnson RE; Jaffe JH; Fudala PJ
    JAMA; 1992 May; 267(20):2750-5. PubMed ID: 1578593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors for completing an inpatient detoxification program among intravenous heroin users, methadone substituted and codeine substituted patients.
    Backmund M; Meyer K; Eichenlaub D; Schütz CG
    Drug Alcohol Depend; 2001 Oct; 64(2):173-80. PubMed ID: 11543987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methadone at tapered doses for the management of opioid withdrawal.
    Amato L; Davoli M; Ferri M; Ali R
    Cochrane Database Syst Rev; 2004 Oct; (4):CD003409. PubMed ID: 15495052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.